Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 1.6 | 1.25 | 1.307 | 1.13 | 163144 | 1.1873991 | CS |
| 4 | -0.01 | -0.78125 | 1.28 | 1.32 | 1.1 | 255291 | 1.21033631 | CS |
| 12 | -1.7 | -57.2390572391 | 2.97 | 4.0695 | 1.1 | 496447 | 1.77968419 | CS |
| 26 | -1.68 | -56.9491525424 | 2.95 | 4.0695 | 1.1 | 279391 | 2.11693012 | CS |
| 52 | -6.03 | -82.602739726 | 7.3 | 7.49 | 1.1 | 230404 | 2.82753677 | CS |
| 156 | -13.25 | -91.2534435262 | 14.52 | 18.68 | 1.1 | 250750 | 8.52962484 | CS |
| 260 | -30.78 | -96.0374414977 | 32.05 | 46.44 | 1.1 | 217974 | 13.58539447 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
